Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Redefining toxic distal axonopathies.

R M LoPachin1

  • 1Anesthesia Research - Moses 7, Montefiore Medical Center, 111 E. 210th St., Bronx, New York, NY, USA. lopaching@aecom.yu.edu

Toxicology Letters
|March 18, 2000
PubMed
Summary

Chemicals can cause central-peripheral distal axonopathy, but traditional signs like axon swelling may not indicate true nerve damage. Re-evaluating toxic axonopathy definitions is necessary.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electron probe x-ray microanalysis: a quantitative electron microscopy technique for measurement of elements and water in nervous tissue cells.

Methods in molecular medicine·2011
Same author

Acrylamide axonopathy revisited.

Toxicology and applied pharmacology·2003
Same author

Acrylamide neuropathy. II. Spatiotemporal characteristics of nerve cell damage in brainstem and spinal cord.

Neurotoxicology·2003
Same author

Acrylamide neuropathy. III. Spatiotemporal characteristics of nerve cell damage in forebrain.

Neurotoxicology·2003
Same author

Acrylamide neuropathy. I. Spatiotemporal characteristics of nerve cell damage in rat cerebellum.

Neurotoxicology·2002
Same author

Nerve terminals as the primary site of acrylamide action: a hypothesis.

Neurotoxicology·2002

Area of Science:

  • Toxicology
  • Neuroscience
  • Cell Biology

Background:

  • Central-peripheral distal axonopathy is a nerve damage type caused by various chemicals.
  • Axon swelling and secondary degeneration are historically considered hallmarks of toxic axonopathies.
  • Molecular mechanisms underlying these presumed hallmarks have been extensively researched.

Purpose of the Study:

  • To investigate the relationship between neurotoxicant dosing conditions and the development of toxic axonopathy hallmarks.
  • To determine if traditional hallmarks of distal axonopathy correlate with neurophysiological deficits or behavioral toxicity.
  • To re-evaluate the definition and classification of toxic distal axonopathies.

Main Methods:

  • Studies involved investigating the rate (mg toxicant/kg/day) and route (intraperitoneal vs. gavage) of intoxication.
  • Neurophysiological deficits and behavioral toxicity were assessed.
  • Morphological changes, including axon swelling and degeneration, were observed.

Main Results:

  • Axon swelling and secondary degeneration were found to be related to specific neurotoxicant dosing conditions (low-dose, subchronic exposure).
  • These morphological changes did not correlate with the development of neurophysiological deficits or classic behavioral toxicity.
  • The presumed hallmarks of distal axonopathy appear to be epiphenomena with uncertain pathophysiologic significance.

Conclusions:

  • The traditional hallmarks of toxic distal axonopathy may not be reliable indicators of nerve damage.
  • Dosing conditions significantly influence the observed morphological changes, suggesting they are epiphenomena.
  • The current definition and chemical classification scheme for toxic distal axonopathies require re-evaluation based on these findings.

Related Experiment Videos